Dinorah Barasch
Hebrew University of Jerusalem
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dinorah Barasch.
Cell Metabolism | 2015
Arieh Moussaieff; Matthieu Rouleau; Daniel Kitsberg; Merav Cohen; Gahl Levy; Dinorah Barasch; Alina Nemirovski; Shai S. Shen-Orr; Ilana Laevsky; Michal Amit; David Bomze; Bénédicte Elena-Herrmann; Tali Scherf; Malka Nissim-Rafinia; Stefan Kempa; Joseph Itskovitz-Eldor; Eran Meshorer; Daniel Aberdam; Yaakov Nahmias
Loss of pluripotency is a gradual event whose initiating factors are largely unknown. Here we report the earliest metabolic changes induced during the first hours of differentiation. High-resolution NMR identified 44 metabolites and a distinct metabolic transition occurring during early differentiation. Metabolic and transcriptional analyses showed that pluripotent cells produced acetyl-CoA through glycolysis and rapidly lost this function during differentiation. Importantly, modulation of glycolysis blocked histone deacetylation and differentiation in human and mouse embryonic stem cells. Acetate, a precursor of acetyl-CoA, delayed differentiation and blocked early histone deacetylation in a dose-dependent manner. Inhibitors upstream of acetyl-CoA caused differentiation of pluripotent cells, while those downstream delayed differentiation. Our results show a metabolic switch causing a loss of histone acetylation and pluripotent state during the first hours of differentiation. Our data highlight the important role metabolism plays in pluripotency and suggest that a glycolytic switch controlling histone acetylation can release stem cells from pluripotency.
International Journal of Food Sciences and Nutrition | 2006
Yong-Seo Park; Soon-Teck Jung; Seong-Gook Kang; Jerzy Drzewiecki; Jacek Namiesnik; Ratiporn Haruenkit; Dinorah Barasch; Simon Trakhtenberg; Shela Gorinstein
The main aim of the present study was the evaluation of proteins and antioxidant potential in ethylene-treated kiwifruit during the first 10 days of ripening. Kiwifruit samples were randomly divided into two groups: treated and untreated. Flesh firmness, sensory value, visual score, free sugars, soluble solids, ethylene biosynthesis, proteins, dietary fibers, total polyphenols and antioxidant potential were determined in both groups. Ethylene (100 ppm) at 20°C for 24 h was used in the treated group. The flesh firmness and acidity in treated samples decreased significantly in the early stage of ripening simultaneously with significant increase in the contents of free sugars, soluble solids, endogenous ethylene production, sensory value, 1-aminocyclopropane-1-carboxylic acid (ACC) content, ACC synthase and ACC oxidase activities, total polyphenols and related antioxidant potential, and was significantly higher than in untreated samples (P < 0.05). Proteins were extracted from kiwifruit and separated by modified sodium dodecyl sulphate polyacrylamide gel electrophoresis. The separation was resolved into 14 protein bands. Some minor quality changes were found only in the 32 kDa band, which was more pronounced in the treated samples. In conclusion, ethylene treatment of kiwifruits leads to positive changes in most of the studied kiwifruit compounds and to an increase in the fruit antioxidant potential. It shortens the ripening time and improves fruit quality by decreasing its flesh firmness and acidity. Some minor changes in the protein profile did not affect the fruit taste and quality.
European Journal of Medicinal Chemistry | 1999
Dinorah Barasch; Omer Zipori; Israel Ringel; Isaac Ginsburg; Amram Samuni; Jehoshua Katzhendler
The mode of action of antitumour anthraquinone derivatives (i.e. mitoxantrone) is not clearly established yet. It includes, among others, intercalation and binding to DNA, bioreduction and aerobic redox cycling. A series of anthraquinone derivatives, with potentially bioreducible groups sited in the side chain, have been synthesized and biologically evaluated. Their redox and cytotoxic activities were screened. Derivatives which bear a 2-(dimethylamino)ethylamino substituent, known to confer high DNA affinity, demonstrated cytotoxicity but not redox activity (beside the anthraquinone reduction). Conversely, derivatives which showed redox activity were not cytotoxic toward the P388 cell line. The results suggest that bioreduction is not the main mode of action in the cytotoxicity of anthraquinones.
Applied Biochemistry and Biotechnology | 2012
Hong-Gi Jang; Buk-Gu Heo; Yong Seo Park; Jacek Namiesnik; Dinorah Barasch; Elena Katrich; Kann Vearasilp; Simon Trakhtenberg; Shela Gorinstein
Seeds and leaves of indigo (Polygonum tinctorium Ait.) plant were investigated and compared with another medicinal plant named prolipid for their properties such as chemical composition, antioxidant, and anticancer effects by Fourier transform infrared, three-dimensional fluorescence spectroscopy, and electrospray ionization-MS in negative mode. It was found that polyphenols, flavonoids, and flavanols were significantly higher in prolipid (P < 0.05), following by indigo mature leaves, immature leaves, and seeds. Methanol extract of mature indigo leaves in comparison with the ethyl acetate extract showed higher inhibition of proliferation. The interaction between polyphenol extracts of indigo mature leaves and BSA showed that indigo has a strong ability, as other widely used medicinal plants, to quench the intrinsic fluorescence of BSA by forming complexes. In conclusion, indigo mature leaves were compared with prolipid. High content of bioactive compounds, antioxidant, fluorescence, and antiproliferative properties of indigo justifies the use of this plant as a medicinal plant and a new source of antioxidants.
Journal of Controlled Release | 2017
Irina Cherniakov; Dvora Izgelov; Dinorah Barasch; Elyad Davidson; Abraham J. Domb; Amnon Hoffman
ABSTRACT Nowadays, therapeutic indications for cannabinoids, specifically &Dgr;9‐tetrahydrocannabinol (THC) and Cannabidiol (CBD) are widening. However, the oral consumption of the molecules is very limited due to their highly lipophilic nature that leads to poor solubility at the aqueous environment. Additionally, THC and CBD are prone to extensive first pass mechanisms. These absorption obstacles render the molecules with low and variable oral bioavailability. To overcome these limitations we designed and developed the advanced pro‐nanolipospheres (PNL) formulation. The PNL delivery system is comprised of a medium chain triglyceride, surfactants, a co‐solvent and the unique addition of a natural absorption enhancer: piperine. Piperine was selected due to its distinctive inhibitory properties affecting both Phase I and Phase II metabolism. This constellation self emulsifies into nano particles that entrap the cannabinoids and the piperine in their core and thus improve their solubility while piperine and the other PNL excipients inhibit their intestinal metabolism. Another clear advantage of the formulation is that its composition of materials is approved for human consumption. The safe nature of the excipients enabled their direct evaluation in humans. In order to evaluate the pharmacokinetic profile of the THC‐CBD‐piperine‐PNL formulation, a two‐way crossover, single administration clinical study was conducted. The trial comprised of 9 healthy volunteers under fasted conditions. Each subject received a THC‐CBD (10.8 mg, 10 mg respectively) piperine (20 mg)‐PNL filled capsule and an equivalent dose of the oromucosal spray Sativex® with a washout period in between treatments. Single oral administration of the piperine‐PNL formulation resulted in a 3‐fold increase in Cmax and a 1.5‐fold increase in AUC for THC when compared to Sativex®. For CBD, a 4‐fold increase in Cmax and a 2.2‐fold increase in AUC was observed. These findings demonstrate the potential this formulation has in serving as a standardized oral cannabinoid formulation. Moreover, the concept of improving oral bioavailability described here, can pave the way for other potential lipophilic active compounds requiring enhancement of their oral bioavailability. Graphical abstract Figure. No caption available.
Biochemical Pharmacology | 2015
Dorit Moradov; Efrat Finkin-Groner; Corina Bejar; Priyashree Sunita; Donna Schorer-Apelbaum; Dinorah Barasch; Alina Nemirovski; Marganit Cohen; Marta Weinstock
Ladostigil is a pseudo reversible inhibitor of acetylcholinesterase (AChE) that differs from other carbamates in that the maximal enzyme inhibition obtainable does not exceed 50-55%. This could explain the low incidence of cholinergic adverse effects induced by ladostigil in rats and human subjects. The major metabolite, R-MCPAI is believed to be responsible for AChE inhibition by ladostigil in vivo. Therefore we determined whether the ceiling in AChE inhibition resulted from a limit in the metabolism of ladostigil to R-MCPAI by liver microsomal enzymes, or from the kinetics of enzyme inhibition by R-MCPAI. Ladostigil reduces TNF-α in lipopolysaccharide-activated microglia. In vivo, it may also reduce pro-inflammatory cytokines by inhibiting AChE and increasing the action of ACh on macrophages and splenic lymphocytes. We also assessed the contribution of AChE inhibition in the spleen of LPS-injected mice to the anti-inflammatory effect of ladostigil. As in other species, AChE inhibition by ladostigil in spleen, brain and plasma did not exceed 50-55%. Since levels of R-MCPAI increased with increasing doses of ladostigil we concluded that there was no dose or rate limitation of metabolism. The kinetics of enzyme inhibition by R-MCPAI are characterized by a rapid formation of the drug-enzyme complex and fast hydrolysis which limits the attainable degree of AChE inhibition. Ladostigil and its metabolites (1-100 nM) decreased TNF-α in lipopolysaccharide-activated macrophages. Ladostigil (5 and 10mg/kg) also reduced TNF-α in the spleen after injection of lipopolysaccharide in mice. However, AChE inhibition contributed to the anti-inflammatory effect only at a dose of 10mg/kg.
Food Analytical Methods | 2018
Yang Gyu Ku; Jong Hyang Bae; Jacek Namieśnik; Dinorah Barasch; Alina Nemirovski; Elena Katrich; Shela Gorinstein
In the recent reports, there are contradictory conclusions about the nutritional and health properties of organic and conventionally growing vegetables. We hypothesized that organic cultivation system results in higher quality of asparagus (Asparagus officinalis L.) because of organic manure and effective organisms. Therefore, new analytical methods were applied in order to find the differences in bioactive compounds between the plants growing under various cultivation systems. Total antioxidant capacities (TAC) of the conventional and organic greenhouse and conventional open-field farming of asparagus spears were determined by 2,2-azino-bis (3-ethyl-benzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picryl-hydrazyl (DPPH), and ferric-reducing antioxidant power (FRAP) assays, and UHPLC-PDA-MS was used for identification of some phenolic acids and flavonoids. Total phenolic compounds (TPC), total flavonoids, rutin, vitamin C, chlorophylls, carotenoids, and the values of TAC, determined in organic growing asparagus spears, were higher than in conventional, but not always significant. The applied for the first time FTIR spectroscopy as an estimation of the differences between the investigated samples showed more prominent bands in the region of polyphenols in organic asparagus spears than in conventional and provides a rapid and precise alternative to other methods. The binding properties of extracted polyphenols to HSA determined by 3D-fluorescence were relatively higher in organic asparagus spears than in other samples. Correlation between the amounts of total polyphenols and flavonoids and their quenching properties showed a linear relationship. All proposed analytical methods can be applied to a variety of studied plants.
Life Sciences | 2006
Shela Gorinstein; Hanna Leontowicz; Maria Leontowicz; Jerzy Drzewiecki; Katarzyna Najman; Elena Katrich; Dinorah Barasch; Kazutaka Yamamoto; Simon Trakhtenberg
Food Chemistry | 2014
Yong-Seo Park; Jacek Namiesnik; Kann Vearasilp; Hanna Leontowicz; Maria Leontowicz; Dinorah Barasch; Alina Nemirovski; Simon Trakhtenberg; Shela Gorinstein
European Food Research and Technology | 2013
Jacek Namiesnik; Kann Vearasilp; Magdalena Kupska; Kyung-Sik Ham; Seong-Gook Kang; Yang-Kyun Park; Dinorah Barasch; Alina Nemirovski; Shela Gorinstein